Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings ...

Pharmaceutical sales data from global healthcare analytics firm IQVIA shows that South Korea’s market for growth hormone ...

IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life sc ...

Farther Finance Advisors LLC decreased its holdings in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 16.5% during the fourth quarter, according to its most recent filing with the SEC.

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo ...

The companies are striving to bring fresh innovations to cancer care, pain management and the weight loss space.

PRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANI’s Nitazoxanide Tablets ...